Andrew Wegrzyn
InvestorPrincipal at SixThirty Ventures
St. Louis, Missouri
Writes $100K – $5M checks · typically $1.5M
Find your path to Andrew
334 people in our graph share verified history with Andrew — schools, employers, funds. One of them is your warm intro.
Dea SurjadiunlockedAndrew: together at University of Missouri-Columbia
Andrew: together at Cultivation Capital
×8Andrew: together at University of Missouri-Columbia
×2Andrew: together at Washington University in St. Louis - Olin Business School
About
Focuses on the intersection of digital health and fintech; previously led oncology treatment innovation at Washington University School of Medicine and was VP of Strategy and Partnership at Citi Ventures.
Contact· self-published, not guessed
Experience
- SixThirtyPrincipalcurrent2021 — presentSt Louis, Missouri, United States
- Edward JonesStrategy Consultant | Firm Analytics2019 — 2021Greater St. Louis
- CitiVice President | Citi Ventures | Strategy & Partnerships2018 — 2019
- CitiManagement Associate | Citi Ventures2017 — 2018
- CitiManagement Associate | Global Consumer Bank2016 — 2017
- Washington University School of MedicineClinical Research Supervisor2014 — 2016St. Louis, MO
- Washington University School of MedicineClinical Research Coordinator I and II & Neuro-Onc Team Lead2012 — 2014St. Louis, MO
- Cultivation CapitalLife Science Investment Analyst - Intern2015 — 2016St. Louis, MO
- Washington University School of MedicineResearch Patient Assistant2009 — 2010
- Owen RoeCellar Worker2008St. Paul, OR
Skills & more
Financial ServicesNonprofit OrganizationsDue DiligenceEarly Stage VenturesHealth InsuranceVenture CapitalClinical Research30Research26Clinical Trials15Data Analysis28Cancer5Statistics11
+12 more
Financial AnalysisBusiness EconomicsLife SciencesInnovation ManagementHealthcarePharmaceutical ResearchBusiness DevelopmentStrategic PartnershipsRelationship DevelopmentManagementPublic SpeakingLeadershipFrom Andrew's professional profile.
Colleagues at SixThirty Ventures
Atul Kamra
Managing Partner at SixThirty Ventures
Brian Matthews
General Partner at SixThirty Ventures
Chandresh Iyer
General Partner at SixThirty Ventures
David Fairman
Venture Partner and CISO-in-Residence at SixThirty Ventures
David Hopkins
Venture Partner at SixThirty Ventures
Doug Wilber
Operating Partner at SixThirty Ventures
Dustin Wilcox
Venture Partner at SixThirty Ventures
Evan Thorpe
Principal, Asia Pacific at SixThirty Ventures
Network4
Atul Kamra
Managing Partner at SixThirty Ventures
Chandresh Iyer
General Partner at SixThirty Ventures
David Fairman
Venture Partner and CISO-in-Residence at SixThirty Ventures
Dustin Wilcox
Venture Partner at SixThirty Ventures
Investors connected to Andrew in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Andrew Wegrzyn?
- Focuses on the intersection of digital health and fintech; previously led oncology treatment innovation at Washington University School of Medicine and was VP of Strategy and Partnership at Citi Ventures.
- Where does Andrew Wegrzyn work?
- Andrew Wegrzyn is Principal at SixThirty Ventures.
- What check size does Andrew Wegrzyn write?
- Andrew Wegrzyn typically writes checks of $100K – $5M.
- Where did Andrew Wegrzyn go to school?
- Andrew Wegrzyn studied at Washington University in St. Louis - Olin Business School (Master of Business Administration (MBA), Finance and Entrepreneurship); University of Missouri-Columbia (MA, Clinical Psychology); University of Illinois Urbana-Champaign (BS).
Same school
Also attended Washington University in St. Louis - Olin Business School102
Shawn MahoneySenior Advisor at RET VenturesSteve BrotmanManaging Partner, Founder at Alpha PartnersElyse RossiDirector of Finance Operations at Red Cell IncubationJ. Spencer FinneyPartner at Sage CapitalSean AinsworthBiotech CEO at FemHealth VenturesAaron SamuelsInvestor, Entrepreneur, Artist, Storyteller
+ 96 more
Also attended University of Missouri-Columbia151
Dea SurjadiSpecial Advisor at Golden Gate VenturesTed CarstensenPlatform Team Manager at HeavybitJacob DeHardtManager, Fund Accounting at Sapphire VenturesAnna OglodzinskaExecutive Assistant at Sapphire VenturesChris KraeuterHead of Communications at ParadigmJeff SturmanExecutive Venture Partner at Caduceus Capital Partners
+ 145 more
Also attended University of Illinois Urbana-Champaign864
Max LevchinCo-founder of PayPal; founder, chairman & CEO of Affirm; partner at SciFi VCLuke NosekCo-founder of PayPal; co-founder of GigafundSundeep PeechuGeneral Partner at Felicis VenturesDeep NisharInvestment Team at General CatalystPrashant ShahPartner at Monta Vista CapitalNoorPartner at Clear Ventures
+ 858 more
Shared employers
Also worked at SixThirty14
Erika WhiteSenior Marketing and Platform Associate at American Family VenturesBrian MatthewsCofounder & General Partner at Cultivation CapitalAtul KamraManaging Partner at SixThirty VenturesDavid HopkinsVenture Partner at SixThirty VenturesChandresh IyerGeneral Partner at SixThirty VenturesRam NagappanVenture Partner at SixThirty Ventures
+ 8 more
Also worked at Edward Jones22
Cooper LaRueAssociate at American Family VenturesKyle KernsCFO and Operations Lead at Cultivation CapitalMychalSenior Analyst at Radicle ImpactAmalie StokkelandSenior Associate at Novo HoldingsCatalina KaziLegal & Compliance Counsel at SR One Capital ManagementRohan ShahCampus Lead at The MBA Fund
+ 16 more
Also worked at Citi1,369
Nina AchadjianInvestor at Index VenturesRishi ModiInvestor at GV (Google Ventures)RustyAdvisor at Clear VenturesKerry WongHead of Investor Relations at Pantera CapitalTori KorineInvestor at OpenView Venture PartnersAnn PauloseSenior Investor Relations Associate at Greycroft
+ 1,363 more
Also worked at Washington University School of Medicine36
Victoria GraceFounding partner of Colle Capital Partners, an opportunistic early-stage technology venture fundKarlos BledsoePrincipal at Seae VenturesMukund SubramanianStrategic Advisor at Advance Venture PartnersBen ScruggsPartner at Hatteras Venture PartnersStephanie RenInvestment Associate at Builders VCTravis ManascoPrincipal at Solas BioVentures
+ 30 more